PHTF2 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 1.132820E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
4.455000E-01
Normal-vs-Stage2
7.875700E-02
Normal-vs-Stage3
1.715640E-01
Normal-vs-Stage4
2.868400E-01
Stage1-vs-Stage2
5.563600E-01
Stage1-vs-Stage3
6.249400E-01
Stage1-vs-Stage4
8.324200E-01
Stage2-vs-Stage3
7.519800E-01
Stage2-vs-Stage4
8.935600E-01
Stage3-vs-Stage4
7.342800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
1.205790E-01
Normal-vs-AfricanAmerican
1.190640E-01
Normal-vs-Asian
3.875700E-02
Caucasian-vs-AfricanAmerican
6.966200E-01
Caucasian-vs-Asian
2.765800E-01
AfricanAmerican-vs-Asian
6.532600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
9.666500E-02
Normal-vs-Female
1.560010E-01
Male-vs-Female
3.486200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
8.535600E-01
Normal-vs-Age(41-60Yrs)
3.518200E-01
Normal-vs-Age(61-80Yrs)
5.726500E-02
Normal-vs-Age(81-100Yrs)
7.504600E-03
Age(21-40Yrs)-vs-Age(41-60Yrs)
5.952800E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
1.431990E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
3.947600E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
1.942890E-03
Age(41-60Yrs)-vs-Age(81-100Yrs)
7.792600E-04
Age(61-80Yrs)-vs-Age(81-100Yrs)
1.673590E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
1.069180E-01
Normal-vs-Daily Drinker
1.900260E-02
Normal-vs-Weekly Drinker
1.077160E-01
Normal-vs-Occasional Drinker
3.161800E-01
Normal-vs-Social Drinker
6.236600E-01
Non Drinker-vs-Daily Drinker
7.327400E-01
Non Drinker-vs-Weekly Drinker
4.450200E-01
Non Drinker-vs-Occasional Drinker
3.587200E-01
Non Drinker-vs-Social Drinker
1.598360E-01
Daily Drinker-vs-Weekly Drinker
1.796160E-01
Daily Drinker-vs-Occasional Drinker
2.225200E-01
Daily Drinker-vs-Social Drinker
1.492390E-01
Weekly Drinker-vs-Occasional Drinker
8.507600E-01
Weekly Drinker-vs-Social Drinker
4.695000E-01
Occasional Drinker-vs-Social Drinker
5.871400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
5.346600E-01
Normal-vs-Grade 2
3.573400E-01
Normal-vs-Grade 3
4.609400E-01
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
6.880600E-01
Grade 1-vs-Grade 3
7.909800E-01
Grade 1-vs-Grade 4
5.346600E-01
Grade 2-vs-Grade 3
3.705200E-01
Grade 2-vs-Grade 4
3.573400E-01
Grade 3-vs-Grade 4
4.609400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
1.850000E-01
Normal-vs-NonDiabetic
9.726000E-02
Diabetic-vs-NonDiabetic
9.990200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
1.954210E-01
Normal-vs-NoPancreatitis
1.495020E-01
Pancreatitis-vs-NoPancreatitis
4.202200E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
1.764560E-01
Normal-vs-N1
5.314300E-02
N0-vs-N1
9.759400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
6.522100E-02
Normal-vs-TP53-NonMutant
7.470500E-02
TP53-Mutant-vs-TP53-NonMutant
7.311400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
